Ro-09-4889

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRo-09-4889
Drug Alias NameRo-0094889Ro-09-4889
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionDihydropyrimidine dehydrogenase inhibitors
TargetsDihydropyrimidine dehydrogenase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharmaceutical Co LtdF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A